Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Drug-protein interactions

Mechanisms of potency

Overcoming drug resistance requires drug–protein interactions that persist in spite of mutations, but such interactions are difficult to characterize. Two-dimensional infrared spectroscopy can reveal the dynamics of how key molecular groups interact, allowing new insights into how some drugs overcome resistance.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The binding of rilpivirine with HIV-1 reverse transcriptase.

References

  1. Kuroda, D. G. et al. Nature Chem. 5, 174–181 (2013).10.1038/nchem.1559

    Article  CAS  Google Scholar 

  2. Bollini, M. et al. J. Med. Chem. 54, 8582–8591 (2011).

    Article  CAS  Google Scholar 

  3. Das, K. et al. Proc. Natl Acad. Sci. USA 105, 1466–14715 (2008).

    Article  CAS  Google Scholar 

  4. Hamm, P. & Zanni, M. T. Concepts and Methods of 2D Infrared Spectroscopy (Cambridge Univ. Press, 2011).

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christopher M. Cheatum.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheatum, C. Mechanisms of potency. Nature Chem 5, 152–153 (2013). https://doi.org/10.1038/nchem.1586

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nchem.1586

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research